Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment.
about
The Relationship between Serum Bilirubin and Elevated Fibrotic Indices among HBV Carriers: A Cross-Sectional Study of a Chinese Population.Reversal of liver cirrhosis: current evidence and expectations.Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.Efficacy and Safety of Entecavir 0. 5 mg in Treating Naive Chronic Hepatitis B Virus Patients in Egypt: Five Years of Real Life Experience.
P2860
Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improvement of liver function ...... years of entecavir treatment.
@en
type
label
Improvement of liver function ...... years of entecavir treatment.
@en
prefLabel
Improvement of liver function ...... years of entecavir treatment.
@en
P2093
P2860
P356
P1476
Improvement of liver function ...... years of entecavir treatment.
@en
P2093
Hyeonsu Park
Hyun Jung Lee
Hyung Joon Yim
Jeong Han Kim
Jong Eun Yeon
Ju Hyun Kim
Kwan Soo Byun
Oh Sang Kwon
Sang Jun Suh
Yun Soo Kim
P2860
P304
P356
10.1111/JGH.13020
P577
2015-06-11T00:00:00Z